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The research activities in this laboratory are performed for X-ray structural analyses of biological macromolecules 
and the investigation of the electronic state in materials as follows: The main subjects of the biomacromolecular crystal-
lography are crystallographic studies on the reaction mechanism of enzymes, the relationship between the multiform 
conformation and the functional variety of proteins, and the mechanism of thermostabilization of proteins. In the inves-
tigation of the chemical state in materials, the characteristics of the chemical bonding in the atom and molecules are 
investigated in detail using a newly developed X-ray spectromator with a high-resolution in order to elucidate the prop-
erty of materials. The theoretical analysis of the electronic states with DV-Xα and WIEN2k, and the development of 
new typed X-ray spectrometer with ultra high-resolution have also been carried out.
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Crystallographic Studies of Binding Mode  
of Protein IC toward Carboxypeptidase Y
The protein IC from Saccharomyces cerevisiae inhibits 
carboxypeptidase Y (CPY) by forming the 1:1 complex. 
We determined the 2.7 Å crystal structure of the IC-CPY 
complex by X-ray crystallography to reveal the inhibitory 
mode of IC against CPY (Figure 1).
Figure 1. Ribbon draw-
ing of the IC-CPY com-
plex at 2.7 Å resolution. 
IC and CPY are shown in 
blue, green, respectively. 
Sulfate ions are repre-
sented by red spheres.
The structure of the IC-CPY complex reveals that IC 
binds to CPY with multiple-binding sites and that the 
N-terminal portion (Ac-Met1I–Lys73I) contains not only 
the N-terminal inhibitory reactive site (Figure 2a) but also 
a large portion of the secondary binding site (Figure 2b). 
In addition, the complex structure reveals that the specific 
binding of the N-terminal acetyl group to the active site of 
CPY is a novel proteinase–protein inhibitor interaction, 
and contributes to a tight interaction with CPY and to its 
complete inactivation.
Figure 2a. Binding of 
the N-terminal inhibitory 
reactive site to the active 
site of CPY. The side-
chains of residues that 
form the catalytic triad 
(red) and substrate-bind-
ing sites of CPY and the 
inhibitory reactive site 
of IC are depicted as 
stick models.
Figure 2b. The secondary binding site 
of IC. The side-chains of residues in- 
volved in the interaction at the binding 
interface are depicted as stick models 
with labels.
To further clarify the proteinase-inhibition mode of IC 
indicated by the three-dimensional structure of the com-
plex with CPY, we analyzed the biochemical properties of 
various IC mutants: the N-terminal unacetylated form 
(unaIC), the N-terminal modified form in which Gly is 
added to the N-terminus to mimic the acetyl group (gIC), 
the N-terminal deleted form (d1-7IC), and the unacetylated 
and C-terminal deleted form (d217-219IC). Gel filtration 
chromatography of mixtures of the native and mutant in-
hibitors with CPY showed that IC, unaIC, gIC, and d217-
219IC produced single peaks in the position corresponding 
to the IC-CPY complex but that the N-terminal deleted 
mutant (d1-7IC) formed no complex with CPY (Figure 3).
Figure 3. Gel filtration analysis of equi-
molecular mixtures of the native and 
mutant forms of IC with CPY. Thick 
lines, the mixtures; thin lines, free CPY 
and IC used as the reference.
The majority of endoproteinase inhibitors and carboxy-
peptidase inhibitors, the three-dimensional structures of 
which were previously elucidated at atomic resolution, 
were directed toward their target proteinases so that they 
interact with the active sites of the proteinases in a sub-
strate-like manner through an inhibitory reactive site 
alone. In contrast, the inhibition and interaction modes of 
IC toward CPY have the three features that are different 
from those of the canonical inhibitors described above: (1) 
the masking of the active site of CPY in a non-substrate-
like manner, (2) the involvement of the N-terminal acetyl 
group introduced posttranslationally in the complete inhi-
bition of the proteinase, and (3) multiple-site binding to 
the proteinase. Thus, the binding of IC toward CPY is the 
prototype of a novel class of proteinase-protein inhibitor 
interactions. Furthermore, considering the loss of the 
binding affinity of the N-terminal deleted mutant (d1-7IC) 
to CPY (Figure 3), it is reasonable to assume that IC firstly 
binds to CPY via the inhibitory reactive site alone, and 
then the secondary CPY-binding site come into contact 
with the enzyme to form the stable complex between the 
proteins.
